Nyxoah Revenue

Nyxoah had revenue of 7.68M EUR in the quarter ending June 30, 2026, with 472.76% growth. This brings the company's revenue in the last twelve months to 21.66M, up 339.14% year-over-year. In the year 2025, Nyxoah had annual revenue of 10.02M with 121.63% growth.

Revenue (ttm)

21.66M EUR

Revenue Growth

+339.14%

P/S Ratio

6.68

Revenue / Employee

140,943 EUR

Employees

154

Market Cap

165.43M USD

Revenue Chart

Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.02M	5.50M	121.63%
Dec 31, 2024	4.52M	173.00K	3.98%
Dec 31, 2023	4.35M	1.26M	40.99%
Dec 31, 2022	3.08M	2.23M	261.97%
Dec 31, 2021	852.00K	783.00K	1,134.78%
Dec 31, 2020	69.00K	-	-
Dec 31, 2019	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company Name	Revenue
Embecta	1.02B
OraSure Technologies	112.41M
Sanara MedTech	109.81M
Pro-Dex	74.64M
KORU Medical Systems	45.11M
Utah Medical Products	36.11M
Stereotaxis	30.07M
Nephros	20.72M

Revenue Rankings

NYXH News

5 days ago - Nyxoah price target lowered to $6 from $11 at Cantor Fitzgerald - TheFly
16 days ago - Nyxoah price target lowered to $2.31 from $2.86 at Baird - TheFly
16 days ago - Nyxoah price target lowered to $6 from $7 at Piper Sandler - TheFly
16 days ago - Nyxoah price target lowered to $4 from $13 at Oppenheimer - TheFly
17 days ago - Nyxoah Q2 Earnings Call Highlights - MarketBeat
17 days ago - Nyxoah Earnings Call Transcript: Q2 2026 - Transcripts
17 days ago - Nyxoah Earnings release: Q2 2026 - Filings
17 days ago - Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results - GlobeNewsWire

More News